Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prognostic factors

  • You have access
    The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
    CHRISTIAN DOLL, CLAUDIUS STEFFEN, BENEDICTA BECK-BROICHSITTER, MAXIMILIAN RICHTER, KONRAD NEUMANN, ANNE POHRT, PHILIPP LOHNEIS, ANNIKA LEHMANN, MAX HEILAND, CARMEN STROMBERGER, ANNEKATRIN COORDES, KORINNA JOHRENS and JAN-DIRK RAGUSE
    Anticancer Research May 2022, 42 (5) 2405-2413; DOI: https://doi.org/10.21873/anticanres.15719
  • You have access
    Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer
    SHINSUKE NAGASAWA, KAZUHITO TSUCHIDA, MANABU SHIOZAWA, YUKIHIKO HIROSHIMA, YAYOI KIMURA, ITARU HASHIMOTO, HAYATO WATANABE, KAZUKI KANO, MASAKATSU NUMATA, TORU AOYAMA, SUMITO SATO, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, SOICHIRO MORINAGA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, HIROSHI SAEKI, YOHEI MIYAGI and TAKASHI OSHIMA
    Anticancer Research September 2021, 41 (9) 4489-4495; DOI: https://doi.org/10.21873/anticanres.15259
  • You have access
    Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy
    RISHU TAKIMOTO, TAKASHI KAMIGAKI, SACHIKO OKADA, HIROSHI IBE, ERI OGUMA and SHIGENORI GOTO
    Anticancer Research August 2021, 41 (8) 4133-4141; DOI: https://doi.org/10.21873/anticanres.15216
  • You have access
    Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival
    CHRISTIAN STAACKMANN, JULIKA RIBBAT-IDEL, SVEN PERNER, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research June 2021, 41 (6) 3205-3210; DOI: https://doi.org/10.21873/anticanres.15107
  • You have access
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
    NAOKI FUKUDA, KAZUHISA TODA, AKIHIRO OHMOTO, XIAOFEI WANG, NAOMI HAYASHI, TETSUYA URASAKI, YASUYOSHI SATO, KENJI NAKANO, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI
    Anticancer Research March 2021, 41 (3) 1683-1691; DOI: https://doi.org/10.21873/anticanres.14932
  • You have access
    Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes
    ELINA URPILAINEN, REETTA ARIMA, PEETER KARIHTALA, ULLA PUISTOLA and ANNE AHTIKOSKI
    Anticancer Research February 2021, 41 (2) 821-828; DOI: https://doi.org/10.21873/anticanres.14834
  • You have access
    Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
    CARSTEN NIEDER, KRISTIAN S. IMINGEN, BARD MANNSAKER and ROSALBA YOBUTA
    Anticancer Research January 2021, 41 (1) 355-358; DOI: https://doi.org/10.21873/anticanres.14783
  • You have access
    Oncological Outcome and Prognostic Factors of Surgery for Soft Tissue Sarcoma After Neoadjuvant or Adjuvant Radiation Therapy: A Retrospective Analysis over 15 Years
    HEINRICH M.L. MUEHLHOFER, BENJAMIN SCHLOSSMACHER, ULRICH LENZE, FLORIAN LENZE, RAINER BURGKART, ALEXANDRA S. GERSING, JAN C. PEEKEN, STEPHANIE E. COMBS, RUEDIGER VON EISENHART-ROTHE and CAROLIN KNEBEL
    Anticancer Research January 2021, 41 (1) 359-368; DOI: https://doi.org/10.21873/anticanres.14784
  • You have access
    EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment
    ANNA SZUMERA-CIEĆKIEWICZ, JAN POLESZCZUK, EWA PASZKIEWICZ-KOZIK, GRZEGORZ RYMKIEWICZ, KAMIL SOKÓŁ, ANITA BORYSIUK, MARTYNA KOTARSKA, DARIA OWCZAREK, MONIKA KAWECKA, BEATA PYTLAK, JAN WALEWSKI and MONIKA PROCHOREC-SOBIESZEK
    Anticancer Research December 2020, 40 (12) 6685-6697; DOI: https://doi.org/10.21873/anticanres.14692
  • You have access
    Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
    JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research December 2020, 40 (12) 7025-7030; DOI: https://doi.org/10.21873/anticanres.14728

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire